PP
EOLS icon

PDT Partners’s Evolus EOLS Stock Holding History

PDT Partners’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60,651
Closed -$730K – 725
2025
Q1 		$730K Buy
+60,651
New +$793K 0.05% 453
2024
Q2 		– Sell
-64,741
Closed -$906K – 686
2024
Q1 		$906K Buy
64,741
+407
+0.6% +$5.29K 0.09% 354
2023
Q4 		$677K Hold
64,334
– – 0.07% 356
2023
Q3 		$588K Hold
64,334
– – 0.07% 391
2023
Q2 		$468K Buy
64,334
+28,405
+79% +$245K 0.06% 385
2023
Q1 		$304K Buy
+35,929
New +$325K 0.04% 460
2021
Q1 		– Sell
-19,590
Closed -$66K – 811
2020
Q4 		$66K Hold
19,590
– – ﹤0.01% 668
2020
Q3 		$77K Sell
19,590
-74
-0.4% -$270 0.01% 692
2020
Q2 		$104K Buy
+19,664
New +$90.6K 0.01% 628

Other funds holding EOLS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PDT Partners's EOLS Position: Q2 2025 in Review

PDT Partners sold out of Evolus (EOLS) in Q2 2025, closing a stake of 60,651 shares — an estimated $730K sold.

PDT Partners first reported a position in EOLS in Q2 2020 and held it in 9 quarters. The position peaked at $906K in Q1 2024. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • PDT Partners reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 60,651 Evolus shares in Q2 2025, an estimated $730K.
  • PDT Partners first reported a position in Evolus in Q2 2020 and held it in 9 quarters.
  • PDT Partners's Evolus position peaked at $906K in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.